Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NJ Labs specializes in analytical chemistry and microbiology testing for pharmaceuticals, nutraceuticals/dietary supplements, cosmetics, food/dairy products and cannabis/CBD. The company offers full-service contract laboratory support with FDA/DEA inspection and ISO/IEC 17025 accreditation. It has a legacy of over 85 years in method development and validation for raw materials and finished products. Services include elemental analysis by ICP-MS, amino acid analysis, gas chromatography testing, USP compendial methods as well as stability studies.
The company does not conduct clinical trials or have its own drug pipeline.
It has recently expanded into cannabis/hemp/CBD product testing to meet new regulatory demands.
CEO Sandra Lee emphasizes transparency in quality assurance documentation and data integrity to withstand FDA scrutiny.
The lab continues to grow staff/facilities to meet increasing regulatory requirements.
No clinical results or programs are reported since the company provides services rather than developing therapeutics.
Pipeline breadth/pipeline/programs fields are therefore not relevant.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NJ Labs.